(Sharecast News) - Tristel reported growing traction for its 'Tristel ULT' disinfection foam in North America on Wednesday, underpinned by positive feedback from leading healthcare institutions and steady sales growth.
The AIM-traded company highlighted the publication of a new case study from the Mayo Clinic, presented at the AORN Global Surgical...

Email this article to a friend

or share it with one of these popular networks:

• DIGG
• FACEBOOK
• STUMBLEUPON
• MIXX
• YAHOO BUZZ
• DELICIOUS
• REDDIT
• NEWSVINE